Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aristotle University Of Thessaloniki
• Collaborator: University of Athens
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• Type II diabetes mellitus

• Poor glycemic control

Exclusion Criteria:

• Heart failure

• Renal disease

• Liver disease

• Cardiovascular event